Peigen Huang
Jiangnan University(CN)Harvard University(US)Massachusetts General Hospital(US)Wuxi Fourth People's Hospital(CN)University of Hong Kong(HK)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Immunotherapy and Biomarkers, Peptidase Inhibition and Analysis, Immunotherapy and Immune Responses
Most-Cited Works
- → Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy(2012)1,064 cited
- → Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy(2016)455 cited
- → CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice(2014)451 cited
- → Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma(2019)400 cited
- → Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer(2019)393 cited
- → Comparison of Pharmacological Activities of Buprenorphine and Norbuprenorphine: Norbuprenorphine Is a Potent Opioid Agonist